tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Eric Criscuolo, 16 are a BUY (43.24%), 21 are a HOLD (56.76%).
Analyst Eric Criscuolo, carries an average stock price target met ratio of 90% that have a potential upside of 14.23% achieved within 214 days. Previously, Eric Criscuolo worked at MIZUHO.
Eric Criscuolo’s has documented 71 price targets and ratings displayed on 10 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CLVS, Clovis Oncology at 24-Aug-2016.
Analyst best performing recommendations are on EXAS (EXACT SCIENCES).
The best stock recommendation documented was for EXAS (EXACT SCIENCES) at 6/15/2016. The price target of $10 was fulfilled within 1 day with a profit of $0.67 (7.18%) receiving and performance score of 71.81.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 24-Mar-2026
$85
5 months 28 days ago
(24-Mar-2026)
51/51 (100%)
$15.41 (22.14%)
294
Buy Since 10-Apr-2025
$105
$-1714.87 (-94.23%)
$85
8 months 1 days ago
(20-Jan-2026)
3/3 (100%)
$2.65 (2.59%)
89
Buy Since 03-Aug-2021
$105
$-1714.87 (-94.23%)
$68
8 months 16 days ago
(05-Jan-2026)
10/10 (100%)
$3.39 (3.34%)
392
Buy Since 09-Jul-2021
$105
$-1714.87 (-94.23%)
$75
9 months 27 days ago
(25-Nov-2025)
16/16 (100%)
$3.87 (3.83%)
607
Buy Since 31-May-2013
$85
9 months 28 days ago
(24-Nov-2025)
20/20 (100%)
$30.28 (55.34%)
240
